Compare BBVA & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBVA | MDT |
|---|---|---|
| Founded | 1857 | 1949 |
| Country | Spain | Ireland |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.0B | 125.3B |
| IPO Year | N/A | N/A |
| Metric | BBVA | MDT |
|---|---|---|
| Price | $23.39 | $100.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 18 |
| Target Price | N/A | ★ $108.44 |
| AVG Volume (30 Days) | 1.2M | ★ 5.8M |
| Earning Date | 01-29-2026 | 02-17-2026 |
| Dividend Yield | 2.77% | ★ 2.92% |
| EPS Growth | 7.95 | ★ 12.98 |
| EPS | 2.04 | ★ 3.69 |
| Revenue | ★ $37,116,038,958.00 | $34,758,000,000.00 |
| Revenue This Year | $17.82 | $8.61 |
| Revenue Next Year | $4.98 | $5.86 |
| P/E Ratio | ★ $11.72 | $26.38 |
| Revenue Growth | ★ 6.03 | 5.34 |
| 52 Week Low | $9.85 | $79.55 |
| 52 Week High | $24.19 | $106.33 |
| Indicator | BBVA | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 60.21 | 59.61 |
| Support Level | $23.31 | $95.17 |
| Resistance Level | $24.19 | $96.99 |
| Average True Range (ATR) | 0.30 | 1.24 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 57.14 | 94.41 |
Despite its Spanish origins, Banco Bilbao Vizcaya Argentaria generates only around one-fourth of its profits in Spain. We expect that on a normalized basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.